Features of Immunological Status in Children with Chronic Bronchitis
DOI:
https://doi.org/10.48112/acmr.v2i3.20Keywords:
Immune Status, Chronic Bronchitis, ChildrenAbstract
Abstract Views: 34
Chronic bronchitis in children is manifested by a number of specific and nonspecific immune responses. In children, there are changes in the system of both cellular and humoral immunity, which are characterized by T-cell immunodeficiency. The aim of the study was to assess the state of the immune status in chronic bronchitis in children. To achieve this goal, 60 children aged 7 to 18 years with chronic bronchitis were examined, who were hospitalized in the pulmonology department of the Republican Specialized Scientific and Practical Medical Center of Pediatrics during 2020-2021. During the period of exacerbation of the disease, a significant decrease in the number of leukocytes, the relative and absolute number of lymphocytes was established. Serum immunoglobulins are one of the main indicators of humoral immunity. In children with chronic bronchitis, on the part of humoral immunity, pronounced hypoimmunoglobulinemia, a sharp increase in the level of IgM, IgA and IgG were noted.
References
Collaborators GCRD. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study. Lancet Respir Med. 2017;8(6):585–596. Available from: https://doi.org/10.1016/s2213-2600(20)30105-3
Collaborators ISLDBIC. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016: the Global Burden of Disease Study. Lancet Glob Health. 2018;6(12):1363–1374. Available from: https://doi.org/10.1016/s2214-109x(18)30409-1
Berliner D, Schneider N, Welte T, Bauersachs J. The Differential Diagnosis of Dyspnea. Dtsch Arztebl Int. 2016;113(49):834–845. Available from: https://dx.doi.org/10.3238/arztebl.2016.0834
Trivedi M, Denton E. Asthma in Children and Adults—What Are the Differences and What Can They Tell us About Asthma? Front Pediatr. 2019;7:256. Available from: https://dx.doi.org/10.3389%2Ffped.2019.00256
MacNee W. Pathogenesis of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2005;2(4):258–266. Available from: https://dx.doi.org/10.1513/pats.200504-045sr
Mogensen TH. Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses. Clin Microbiol Rev. 2009;22(2):240–273. Available from: https://dx.doi.org/10.1128/cmr.00046-08
Chen K, Kolls JK. T Cell–Mediated Host Immune Defenses in the Lung. Annu Rev Immunol. 2013;31(1):605–633. Available from: https://dx.doi.org/10.1146/annurev-immunol-032712-100019
Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2):S3–S23. Available from: https://dx.doi.org/10.1016/j.jaci.2009.12.980
Fahy JV, Dickey BF. Airway Mucus Function and Dysfunction. N Engl J Med. 2010;363(23):2233–2247. Available from: https://dx.doi.org/10.1056/nejmra0910061
McPherson R, Tsoukas C, Baines MG, Vost A, Melino MR, Zupkis RV, et al. Effects of lovastatin on natural killer cell function and other immunological parameters in man. J Clin Immunol. 1993;13(6):439–444. Available from: https://dx.doi.org/10.1007/bf00920019
OAI-PMH 
